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Abstract
The unique hazard posed to the pleural mesothelium by asbestos has engendered concern in potential for a
similar risk from high aspect ratio nanoparticles (HARN) such as carbon nanotubes. In the course of studying the
potential impact of HARN on the pleura we have utilised the existing hypothesis regarding the role of the parietal
pleura in the response to long fibres. This review seeks to synthesise our new data with multi-walled carbon nano-
tubes (CNT) with that hypothesis for the behaviour of long fibres in the lung and their retention in the parietal
pleura leading to the initiation of inflammation and pleural pathology such as mesothelioma. We describe evi-
dence that a fraction of all deposited particles reach the pleura and that a mechanism of particle clearance from
the pleura exits, through stomata in the parietal pleura. We suggest that these stomata are the site of retention of
long fibres which cannot negotiate them leading to inflammation and pleural pathology including mesothelioma.
We cite thoracoscopic data to support the contention, as would be anticipated from the preceding, that the parie-
tal pleura is the site of origin of pleural mesothelioma. This mechanism, if it finds support, has important implica-
tions for future research into the mesothelioma hazard from HARN and also for our current view of the origins of
asbestos-initiated pleural mesothelioma and the common use of lung parenchymal asbestos fibre burden as a
correlate of this tumour, which actually arises in the parietal pleura.
Background
The experience with asbestos highlighted that high
aspect ratio particles (fibres) pose an additional hazard
to the lung beyond that produced by conventional com-
pact particles and gave rise to the discipline of fibre tox-
icology. Over several decades up to the present, fibre
toxicology has evolved a structure activity paradigm that
explains the pathogenicity of fibres that is the most
robust in particle toxicology. Whilst this paradigm
explains the relationship between fibre characteristics
and their pathogenicity, the exact sequence of events,
f o l l o w i n gf i b r ed e p o s i t i o nl e a d i n gt oaf i b r e - t y p eh a z a r d
to the pleura and pleural mesothelium has not been
clarified. In particular we poorly understand the
mechanism whereby fibres seem to selectively deliver
their dose to the parietal pleura, whilst the visceral
pleura is not initially affected [1]. There has been no
unifying hypothesis as to exactly how, within the normal
understanding of particle clearance of particles out of
the lungs, sustained fibre ‘dose’ is delivered to the parie-
tal pleura sufficient to produce the distinctive profile of
pleural effects associated with fibre exposure in man
and animals. In this paper we advance a plausible
hypothetical mechanism that emphasises translocation
of a fraction of all deposited particles and fibres to the
pleural space but the retention of only long fibres in the
parietal pleura. This retention of fibre dose at the parie-
tal pleura then serves as the driver that initiates
mesothelial injury and inflammation that over time
leads to pleural pathology, including mesothelioma. This
mechanism is, we contend, generalisable to carbon
nanotubes and potentially to other high aspect ratio
nanoparticles (HARN) that are currently a cause for
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which represent the driving stimulus for this work.
The application of this hypothesis to nanotubes arises
from our initial work regarding the similarities in
length-dependent mesothelial inflammogenicity of asbes-
tos and carbon nanotubes in the peritoneal cavity [2].
The role of failed peritoneal and pleural cavity clearance
of long fibres in their pathogenicity was advanced in its
essential form by Kane and co-workers [3,4]. Boutin and
co-workers [5-7] have also made essentially the same
suggestion as regards asbestos and clearance from the
parietal pleura in relation to human asbestos-related
mesothelioma. We therefore fully recognise these intel-
lectual precedents in our restatement and elaboration of
the hypothesis here in relation to our work with long
and short nanotubes in the pleural cavity [2]. This new
work, which is mentioned to a small extent in this
review, is being submitted for full peer-review elsewhere
(Murphy, F., Poland, C.A., Ali-Boucetta, H., Al-Jamal K.
T . ,D u f f i n ,R . ,N u n e s ,A . ,H e r r e r o ,M - A . ,M a t h e r ,S .J . ,
Bianco, A., Prato, M., Kostarelos, Donaldson, K. Long
but not short nanotubes are retained in the pleural
space initiating sustained mesothelial inflammation. Sub-
mitted for publication)This present review sets out the
anatomical and pathophysiological background concern-
ing the behaviour of particles and fibres in the pleural
space and elaborates the evolving hypothesis that might
explain how long fibres and long nanotubes might deli-
ver ‘dose’ to the parietal pleura.
Fibres and the pleural mesothelium
Particles tend to deliver their effects to the lung itself in
the form of fibrosis or lung cancer. PM10 particles also
affect susceptible populations, exacerbating existing air-
ways disease and cardiovascular disease, probably via
pro-inflammatory effects emanating from the lungs. The
additional hazard posed by fibres relates to the meso-
thelial lining of the pleural cavity and to some extent
the peritoneal cavity. Individuals exposed to asbestos
demonstrate a wide range of pleural pathologies includ-
ing pleural effusion (a build up of fluid within the
pleural space), pleural fibrosis and pleural mesothelioma
[8]. A variable, usually small, proportion of mesothelio-
mas developing in individuals exposed to asbestos arise
in the peritoneal cavity, likely as a result of fibre translo-
cation from the pleural cavity to the peritoneal cavity
[9]. The mechanism of production of pleural meso-
thelioma is not well understood although various
mechanisms have been advanced [10]. However some
contact between fibres and mesothelial cells is a reason-
able supposition (see below) and numerous studies have
demonstrated effects such as genotoxicity [11] and pro-
inflammatory effects [10] following exposure of
mesothelial cells to asbestos and other fibres in vitro.
The classical fibre pathogenicity structure:activity
paradigm
Several decades of fibre toxicology have lead to an over-
arching fibre toxicology structure:activity paradigm
involving length, diameter and biopersistence (reviewed
in [12] Figure 1).
The fibre paradigm identifies the geometry of fibres as
their most important toxicological characteristic and not
the chemical make-up, except in so far as the composi-
tion makes a contribution to biopersistence (see later).
This independence from composition is evident in the
fact that the paradigm embraces fibres composed of
diverse materials including amphibole and serpentine
asbestos minerals, vitreous and ceramic fibres and an
organic fibre (reviewed in [12]). Diameter is important
Figure 1 Diagram illustrating a pathogenic fibre according to the pathogenicity paradigm and the role of particle characteristics.
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defining aerodynamic diameter (Dae)a n dt h ed e p e n -
dence of pulmonary deposition on Dae [13]. Clearance
from beyond the ciliated airways is dominated by slow,
macrophage-mediated clearance [14] and so fibres
which deposit there have the potential to contribute
most to build-up of dose. Length impacts little on Dae
f o rt h i nf i b r e s[ 1 5 ]e x c e p tw h e nl e n g t hi ss u f f i c i e n tt o
cause interception, a mechanism of particle deposition
that is confined to fibres, involving the centre of gravity
of the fibre following the airstream at a bifurcation
whilst the tip of the fibre makes contact with the wall,
resulting in deposition. The penetration of long fibres
(>50 μm) beyond the ciliated airways is explicable on
the basis that the aerodynamic diameter of a straight
fibre is around 3 times its actual diameter [15]. This
results from its alignment with the airflow as the fibres
move aerodynamically through these tubes, aligned
along the axis of the bronchial tree.
The evidence demonstrating that length is a key factor
in pathogenicity of fibres comes from a number of
sources but the best data are from experimental toxicolo-
gical studies where it is possible to isolate length cate-
gories and assess their effects, unlike the mixed nature of
human exposures. In the seventies Stanton carried out a
large number of studies aimed at understanding the role
of fibre characteristics in mesothelioma using implanta-
tion of fibres in gelatin, directly onto the pleural
mesothelial surface. Although this is a highly artificial
exposure, in a summary of these studies [16] Stanton
identified that carcinogenicity was related to ‘durable’
fibres longer than 10 μm. In the study by Davis et al. [17]
rats were exposed in a chamber to clouds with equal air-
borne mass concentration of either long amosite asbestos
f i b r eo ras h o r tf i b r ea m o s i t es a m p l eo b t a i n e df r o mi tb y
ball-milling. After lifetime exposure there was substantial
tumour and fibrosis response in those rats exposed to the
long amosite and but virtually no response in rats
exposed to the short amosite. Adamson et al.u s e dl o n g
and short crocidolite and following deposition in mouse
lungs reported fibrosis [18] and proliferative responses
[19] at the pleura with the long, but not the short sam-
ples. The mouse peritoneal cavity has been used as a
model of direct mesothelial exposure and much greater
toxic [20], inflammatory [21] and granuloma-generating
[4] responses were evident in mice that were exposed to
high doses of long fibres than was seen with shorter
fibres. In vitro systems have also demonstrated the
greater potency of long compared to short fibres in assays
of pro-inflammatory and genotoxic activity [22-27].
Biopersistence and length interact in determining the
clearance of long fibres from the lungs since long fibres
may undergo dissolution which could result in complete
dissolution, or most likely weakening of the fibre such
that it undergoes breakage into shorter fibres, which can
be more rapidly cleared than long fibres. The retention
half-time (T1/2) of a compact, inert, respirable, tracer
particle, or a short fibre, in the respiratory tract of a rat
is commonly ~60 days [28]. However long fibres (> 20
μm) are more slowly cleared as they cannot be easily
enclosed by macrophages [29] leading to frustrated pha-
gocytosis (see below). Thus long fibres are more likely
to accumulate in the lungs allowing the long fibre dose
to build up. Long fibres that are composed of bio-solu-
ble (non-biopersistent) structural components can
undergo weakening and breakage in the lungs [30]. The
knowledge described above lead to the evolution of the
fibre pathogenicity paradigm show in Figure 1 highlight-
ing that a pathogenic fibre is one that is long, thin and
biopersistent.
Carbon nanotubes and the classical fibre
pathogenicity paradigm
Carbon nanotubes (CNT) are one of the most important
products of nanotechnology, representing significant
investment and are already incorporated into a large
number of products and this is likely to increase. How-
ever, the essentially fibrous structure of CNT has lead
to concern that they might cause asbestos-like pathology
in the lung and mesothelium [2,31]. Carbon nanotubes
can exist as compact tangles of nanotubes that are
essentially particles, or as longer, straighter ‘fibres’ and
we would anticipate that the hazard from these two dif-
ferent forms of carbon nanotube would differ. Particle
effects would be confined to the lungs as fibrosis and
cancer whilst fibres, exemplified by asbestos, are known
have the same types of pulmonary effect but to also
affect the pleura. We previously carried out a study
where we exposed the peritoneal mesothelium, as a con-
venient model for the pleural mesothelium, to carbon
nanotubes to determine whether they showed an asbes-
tos-like, length-dependent toxicity [2]. These studies
revealed that carbon nanotubes in the form of long
fibres showed a similar, or greater, propensity to pro-
duce inflammation and fibrosis in the peritoneal cavity,
to that produced by long asbestos. In contrast neither
short asbestos fibres nor short, tangled CNT caused any
significant inflammation. One important underlying pro-
cess in the toxicity of long fibres is the failure of the
macrophage to completely enclose them- termed incom-
plete or ‘frustrated’ phagocytosis, which is a pro-inflam-
matory condition. Long carbon nanotubes very likely
cause inflammation via this process when long enough,
i.e. longer than about 15 μm [2]. Frustrated phagocytosis
of long fibres as it likely applies to asbestos and carbon
nanotubes is illustrated in Figures 2 and 3.
In terms of the fibre pathogenicity paradigm, it is pos-
sible for carbon nanotubes to be pathogenic by being
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also possible for CNT to exist in forms that do not
comply with the paradigm for a pathogenic fibre. For
example CNT can exist as short forms, and longer but
tangled forms (see right side of Figure 2), neither of
which would pose a problem to macrophages in terms
of phagocytosis or clearance. Whilst singlet nanotubes
are always thin they form tangles, ropes and wires of
intertwined tubes and these can be thicker, although
still likely to be thin enough to be respirable. However,
in larger tangles and bundles the aerodynamic diameter
may well increase beyond respirability. Graphene, the
basic structural component of CNT is an exceedingly
strong material [31] and so is likely to be biopersistent
when the graphene is pristine, with few defects and
underivatised, and that is suggested by our own data (in
preparation). However CNT derivatised by some che-
mistries, with increased amounts of defects in the gra-
phene structure, may be less biopersistent.
Injection of fibres into the peritoneal cavity as a
surrogate for fibre effects in the pleural cavity:
the role of retention of long fibres in the
peritoneal cavity in long fibre-induced
inflammogenicity and fibrogenicity
The peritoneal cavity and its viscera are covered by a
mesothelium and this was recognised as a convenient
surrogate for the pleural cavity mesothelium in fibre stu-
dies over 30 years ago. Subsequently asbestos fibres
were found to produce inflammation [21] and
mesotheliomas [32] in the peritoneal cavity following
injection. Although the peritoneal cavity would not be
expected to have evolved the efficient clearance mechan-
isms shown by the lungs, in fact it does have a system
for removing particles. Instilled particles are rapidly
drawn cranially in the lymph flow through the dia-
phragm to the parathymic lymph nodes [33]. This
involves transit through the diaphragm via stomata
which are pore like structures less than 10 μmi nd i a -
meter (Figure 4) linking the peritoneal cavity to the
underlying lymphatic capillaries and which were impli-
cated in fibre effects by Kane and co-workers in 1987
[4].
K a n ea n dc o - w o r k e r s[ 3 ]n o t e dt h a tl o n ga s b e s t o s
fibres accumulated preferentially at the peritoneal face
of the diaphragm around the stomata since they could
not be cleared through them due to their length. Kane
et al. contended that retention of long fibres at the dia-
phragmatic mesothelial surface initiated inflammation,
proliferation and granuloma formation. Short fibres did
not cause this effect, easily exiting through the stomata.
However, if short fibre were injected at such high dose
that their sheer volume blocked the stomata this pre-
vented clearance allowing retention, resulting in inflam-
mation [3]. We confirmed that low dose exposure of the
mouse peritoneal cavity to long multi walled carbon
nanotubes (MWCNT) [34] resulted in accumulation of
the long CNT at the diaphragm, suggesting that they
are also too long or bulky to exit through the stomata.
Retention of the long CNT in the peritoneal cavity
Figure 2 The frustrated phagocytosis paradigm as it relates to long and short fibres of asbestos (left) and various forms of carbon
nanotubes (right). When confronted by short asbestos fibres or tangled, compact carbon nanotube ‘particles’ the macrophage can enclose
them and clear them. However the macrophage cannot extend itself sufficiently to enclose long asbestos or long nanotubes, resulting in
incomplete or frustrated phagocytosis, which leads to inflammation.
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cells in the peritoneal lavage (Figure 5) and in the gran-
ulomas (Figure 6) [2]. Short, tangled CNT were not
retained and were never seen at the diaphragm or vis-
cera and did not induce inflammation or granuloma for-
mation, their absence from sections strongly suggesting
that were cleared through the stomata.
Therefore, we would postulate that there are two
important parts to the mechanism of the pro-inflamma-
tory effects of long fibres in the peritoneal cavity, shared
by both asbestos and long MWCNT
i) failure of long fibres to negotiate the diaphragmatic
stomata with subsequent retention of the long fibre
dose at the diaphragm; this contrasts with smaller parti-
cles which easily leave the peritoneal cavity through the
diaphragmatic stomata to accumulate in the parathymic
nodes [33],
ii) at the point where the long fibre dose accumulates
at the peritoneal face of the diaphragm macrophages
attempt to phagocytose the long fibres; they then
undergo frustrated phagocytosis stimulating inflamma-
tion and mesothelial cell damage, leading to chronic
inflammation and granuloma development [2].
The consequences of pro-inflammatory and fibrogenic
effect of long fibre retention at the diaphragm were
most evident in the extent of the granuloma/fibrosis
response seen 6 months following instillation of 10 μg
of long or short nanotubes (see [2] for a full description
of the NT tang 2 and NT long 1 nanotubes used in this
study). As Figure 6 shows, the presence of quite a large
aggregate of short/tangled nanotubes produced very lit-
tle tissue reaction (Figure 6A and 6B). In contrast, loose
aggregates and singlet fibres of long nanotubes caused a
florid granuloma response( F i g u r e6 Ca n d6 D ) .T h e
multi-layered basketwork -like arrangement of largely
acellular collagen in the granuloma is strongly reminis-
cent of the structure of an asbestos-induced pleural pla-
que (see later).
Figure 3 Frustrated phagocytosis (arrows) and the associated
acute inflammatory reaction in the bronchoalveolar lavage of
mice whose lungs have been instilled with long nanotubes.
Aspiration of 50 μg of long fibrous multi-walled carbon nanotubes
(CNT) into the lungs of C57BL/6 mice caused an acute inflammatory
reaction at 24 hrs typified by a large influx of inflammatory
neutrophils (PMN) into the bronchoalveolar lavage. CNT bundles
and singlet fibres were seen both within macrophages (hollow
arrow) and extending outside the macrophage in the process of
incomplete or frustrated phagocytosis (black arrows). All images at
taken at ×1000 magnification.
Figure 4 SEM of the surface of the peritoneal face of the
diaphragm of a mouse showing the stomata (arrows)
reproduced with permission from Moalli et al [4].
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the question as to the extent of translocation of fibres
from the pleural space to the peritoneal cavity. Little is
known about this and it has never been quantified in
man. The mere fact that far-and-away most mesothelio-
mas arise in the pleural cavity suggests that long fibres
are retained there, so short fibres can reach the perito-
neal cavity but, by virtue of their low pathogenicity, gen-
erally do not cause much harm there.
Pleural structure and function
Although the peritoneal cavity serves as a convenient
model to study mesothelial impacts of fibres, the pri-
mary mesothelial target for inhaled fibres is the pleural
mesothelium. The chest cavity, or pleural cavity is the
cavity that surrounds the lungs and heart, comprising
the ribs and associated muscles and connective tissue.
This cavity is covered by the parietal pleura, which is
attached to the chest wall and is covered by a continu-
ous ‘parietal’ mesothelial cell layer. The lungs themselves
are enclosed by the visceral pleura which is integral to
the lung surface and which has a surface ‘visceral’
mesothelial layer. The tight fit of the lungs to the inside
of the chest wall means that the two mesothelial layers
are closely apposed and there is a thin space between
them that contains the pleural fluid (Figure 7) and also
a population of pleural macrophages.
The visceral and parietal mesothelium are both com-
posed of a single layer of mesothelial cells, a basal
lamina of connective tissue and a loose connective tissue
layer with blood and lymph vessels. Mesothelial cells
have several functions in normal pleural action [35].
Pleural fluid is constantly produced by hydrostatic pres-
sure from the sub-pleural capillaries [35], supplemented
by glycoproteins secreted by the mesothelial cells [36].
The pleural fluid and its constant outflow (see below)
maintains tight coupling of the lungs to the chest wall,
allowing diaphragmatic muscle contraction and relaxa-
tion to expand and passively relax the lungs during
breathing movements. The pleural space is a narrow,
Figure 5 Multinucleate giant cell lavaged from the peritoneal cavity of a mouse instilled with long carbon nanotubes. CNT are visible in
the cytoplasm (arrows); PMN = Poymorphonuclear Neutrophilic Leukocyte; L = lymphocyte (Magnification ×100).
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rapidly fixed at death and presumed to be similar in size
in humans [35]. The pleural fluid turns over rapidly
[37], continuously exiting through stomata in the parie-
tal (not the visceral) pleura via lymphatic capillaries;
these stomatal openings on the parietal pleural surface
are between 3 and 10 μm in diameter (Figure 8). They
are often found in association with ‘milky spots’,l a r g e
accumulations of leukocytes present on the parietal
pleura [38] and presumed to be involved in immune
activity in the pleural space. The pleural fluid outflow
through these stomata drains to the lung lymph nodes
in the region of the mediastinum and this pathway is
important in the clearance of particles and fibres that
reach the pleural space (see below). The drainage of
fluid from the pleural space carries particles in the
lymph to the hilar lymph nodes, mediastinal lymph
nodes, parasternal lymph nodes and posterior mediast-
inal lymphoid tissue [39]. The stomata are most densely
situated in the most caudal and posterior intercostal
Figure 6 Lesions on the peritoneal face of the diaphragm after intra-peritoneal injection of 2 forms of carbon nanotube differing in
aspect ratio. The figure shows sections through the peritoneal aspect of the diaphragm of C57BL/6 mice 6 months after intra-peritoneal
injection of 10 μg of two separate forms of multi-walled carbon nanotube (CNT). Sections are stained with Haematoxylin & Eosin (panels A and
C) or Picro-sirius red stain which stains collagen bright red (panels B and D). Mu = Muscle of diaphragm; G = granuloma; small arrows =
mesothelium; large arrows = carbon nanotubes. C and D show a large granuloma sitting atop the muscle layer, caused by the presence of CNT
in the form of long fibres (open arrows). A and B show the contrasting response to CNT in the form of tightly bound dense spherical
aggregates (open arrows) which produces minimal tissue reaction. All images are taken at ×100 magnification bar = 100 μm.
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cranial and anterior intercostal regions [40].
A fraction of all deposited particles transit
through the pleura, exit via the stomata and form
‘black spots’ around the stomata
Applying the classical dose/response toxicology para-
digm to the unique pleural pathology seen with asbestos
and other fibre exposures, it may be assumed that since
the response occurs at the pleura, the dose must be
applied at the pleura. It might be argued therefore that
since fibres produce pleural pathology whilst particles
do not, fibres must reach the pleura and particles must
not. However, a body of literature exists to the effect
that in fact a proportion of all deposited particles reach
the pleura, pass through the pleural space and exit
through the stomata. In the process of this they elicit
range of low to higher grade responses there in the
form of parietal pleural ‘black spots’.
Evidence that all particles pass through the pleura
comes from a substantial literature concerning the
almost universal existence of these “black spots”,
Figure 7 Diagrammatic representation of the relationship between the visceral and parietal pleurae. The visceral pleura (VP) and the
parietal pleura (PP) are seen in close apposition separated by a pleural space that contains a small volume of pleural fluid (pf). Contact between
the 2 pleurae is made via the mesothelial cell layers (m) on the surface of the parietal and visceral pleurae. Pleural macrophages (PM) are
present in the pleural space. The rigid chest wall is tightly locked to the lungs by the adherence of the visceral pleura to the parietal pleura
allowing movements of the chest wall caused by the action of the diaphragmatic muscle and intercostal muscle (IM) to expand and relax the
lungs, allowing pulmonary inspiration and expiration. The pathway for particles to reach the pleural space is unknown but the path for an
airborne particle (1) that deposits in the distal alveoli (2) is shown as it passes into the interstitium (3) enters the pleural space (4) and exits
through a stoma in the parietal pleura (s) into a lymphatic capillary (lc, 5) to enter the lymph flow to the lymph nodes in the mediastinum and
central lung.
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mark the stomata and arise where particles must focus
to exit the pleural space at the stomata and where they
enter the sub-mesothelial connective tissue around the
stomatal mouths. In the study by Mitchev et al. [41],
150 consecutive necropsies of urban dwellers were
examined in Belgium. Of the 96 male and 54 female
necropsies, whose age ranged from 22-93 years, black
spots were almost invariably seen (>90% of autopsies)
on the parietal pleura. The authors noted that their
location appeared to be related to the structures respon-
sible for the lymphatic drainage of the pleural cavity and
they considered these to mark the points of pleural fluid
resorption. Black spots were also present on the pleural
face of the diaphragm, suggesting that there is pleural
fluid outflow in a caudal direction. The black spots in
the Mitchev study of normal individuals at autopsy
clearly reflects that deposited soot particles normally
pass through the pleura some of them accumulating in
the parietal pleural wall forming black spots. The black
spots contain particles and elicit a tissue response which
is a low grade in city dwellers, where there is accumula-
tion of dust-laden macrophages and lymphocytes. In
coal miners, however, with their large exposures to par-
ticles, the mixed dust particles trigger a higher-grade
inflammatory reaction of the parietal pleura with conco-
mitant low grade fibrosis in the ‘black spots’ which are
very pronounced [42]. Occasionally pleural inflammatory
reactions to interstitialisation of the mixed dust at the
black spots are more pronounced, producing more
severe granulomatous structures with concentrically
arranged collagen fibres [42]. In one study [42], 12
patients with black spots (8 at autopsy and 4 surgically)
who were largely miners, had their black spots removed
and sectioned for histological purposes. As might be
expected with such high dust exposure, the black spots
were extremely well-demarcated and followed the lines
of lymph flow across and through the parietal pleura.
The most severe and frequently-documented example
of pleural response to dust is asbestos pleural plaques.
Pleural plaques are commonly seen in asbestos-exposed
individuals occurring only on the parietal pleura and
diaphragm as discrete, raised, irregularly shaped areas a
few millimetres to 10 centimetres in size, having a grey-
ish to ivory white colour depending on their thickness
[43]. It is important to note that pleural plaques occur
in greatest profusion in exactly the sites where the
stomata are in greatest profusion i.e. pleural plaques are
‘...most commonly found on the posterior wall of the
lower half of the pleural spaces, those in the intercostal
Figure 8 Scanning electron micrograph image of chest wall from a normal rat showing the parietal pleural surface with mesothelial
cells (M) and a stoma (white arrows, St) that is approximately 3 μm in diameter.
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to the ribs above and below...’. On histological section
plaques can be seen to be composed of dense bands or
weaves of avascular and largely acellular collagen, with
only the occasional fibroblast nucleus to be seen; they
are sometimes calcified [44]. These collagenous plaques,
whilst commonly seen in association with asbestos expo-
sure are not unique to it, being found following pleural
infection or trauma and so can be presumed to be the
way that the pleura reacts to injury [44].
Thus there is clear evidence that a proportion of all
deposited particles, most commonly urban particulate
matter, reach the parietal pleura where they may inter-
stitialise around the stomata and elicit responses. The
severity of the response is dependent on the intrinsic
toxicity of the dust, with increasing levels of inflamma-
tory/fibrotic response as follows:- soot < mixed mineral
dust < short asbestos. The benign nature of asbestos
pleural plaque-type responses is evident in the lack of
reports of mesothelioma in city dwellers or coalminers
despite the prevalence of black spots in these popula-
tions and the notable lack of asbestos pleural plaque
progression to malignancy [45]. Since normal asbestos
pleural plaques are benign and not pre-cancerous, we
hypothesise that pleural plaques are a special case of a
‘black’ spot caused by short asbestos fibres which elicit
an unusually florid collagenous response, or as a result
of a very high dose of short fibres reaching the peri-sto-
matal wall. The emphasis on shortness here is important
since the key feature of black spots, we contend, is that
the particles and short fibres are small enough to
negotiate the stomatal openings where they mostly clear
to the lymph nodes whilst some interstitialise into the
sub-mesothelial interstitiumt h r o u g ht h ep r o x i m a ll y m -
phatic capillary walls. As described below, this contrasts
with events that may occur with long fibres; these can-
not negotiate the stomata leading to retention at the
stomatal openings, initiating a very different pathobiolo-
gical sequence of events culminating in a different
pathological outcome.
Our knowledge regarding the pathway by which parti-
cles reach the pleura from the lung parenchyma is well
summed up in a recent review ‘... How asbestos fibres
that have impacted the airway wall migrate to the
pleural surface ..... is quite obscure. ..’ [1]. Lymphatic
flow from the parenchyma to the pleural space is one
obvious possibility [46] but such a pathway, if it exists,
is not well-documented [1]. A fluid dynamics model of
fibre translocation highlights two possible pathways [47],
the first of these being by normal lymph flow centrally
to the mediastinum and then into the blood via the
thoracic duct followed by extra-vasation in the pleural
capillaries during the formation of pleural fluid. This
rather tortuous route disregards the filtering role of the
lymph nodes and seems to us to be intuitively unlikely.
The second route requires inflammation in the parench-
yma, caused by the fibres, to reverse both the normal
flow of lymph and the normal trans-pleural pressure,
resulting in a net flow of fluid and fibres directly into
the pleural space from the underlying parenchyma [47].
This latter process cannot be the explanation for normal
transit of particles to the pleura that gives rise to black
spots (see above) in normal people, who have no pul-
monary inflammation. Therefore, even if such an
inflammation-dependent pathway exists, a pathway that
is independent of inflammation clearly operates for
compact particles in normal people. Further research is
needed to establish the mechanism of transport of fibres
to the pleural space.
Long fibre retention at the stomata of the
parietal pleura
So from the above there is good evidence to support the
contention that a fraction of all deposited particles
reach the pleura by an obscure pathway and that short
fibres and compact particles leave the pleura through
the stomatal openings. Most of the particles are trans-
ported to lymph nodes and somee n t e rt h ei n t e r s t i t i u m
at the mouth of the stoma to form a ‘black spot’ or
equivalent. Long fibres that reach the pleural space,
however are an exception to this, since they have the
potential to physically block the stomata due to their
difficulty in negotiating the bend into the stoma which
would result in interception of the ends of the fibre
with the walls of the stomatal openings and with the
lymph vessels walls themselves. This is likely to lead to
mesothelial and endothelial cell damage at this site,
inflammation and the accumulation of pleural macro-
phages attempting to phagocytose these retained fibres.
The macrophages are likely to undergo frustrated pha-
gocytosis in attempting to enclose the long fibres and so
release cytokines and oxidants. This would lead to
further inflammation, fibrosis and genotoxicity in the
bystander mesothelial cells in these areas of congestion
around the stomatal entrances. Direct interaction
between retained long fibres and mesothelial cells
around the stomata could also result in direct genotoxi-
c i t y .E v e n t u a l l ys o m es t o m a t aa r el i k e l yt ob ee n t i r e l y
blocked by cells and fibres. Figure 9 demonstrates dia-
grammatically the difference between formation of black
spots and pleural plaques with particles and short fibres
(A), compared to the response to long fibre retention at
parietal stomata (B).
This means that that the primary lesion caused by
long fibres must form at the parietal pleura, the site of
retention of long fibre dose and therefore the site of
response. Mesothelioma would therefore originate not at
t h ev i s c e r a lp l e u r ab u ta tt h ep a r i e t a lp l e u r a .T h e r ei s
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and numerous studies using thoracoscopy have con-
firmed that the origin of mesothelioma is the parietal
pleura [6]. This is reflected in the staging of mesothe-
lioma which recognises that early mesothelioma is con-
fined to the parietal pleura, while more advanced
mesothelioma involves the visceral pleura [48]. Indeed,
the prognosis for mesothelioma when it only involves
the parietal pleura is much better by around 30 months,
than the prognosis arising when mesothelioma involves
visceral pleura [6]. This reflects the earliness of the dis-
ease stage when it is still confined to the parietal pleura.
From a toxicological viewpoint this means that the
focus of attention in trying to determine whether any
fibre is likely to cause mesothelioma should not be
focussed on the question ‘Do fibres reach the pleura?’
Figure 9 A) diagram showing the events leading up to formation of black spots. A1) particles enter the pleural space; A2) in focusing to
exit via the stoma (St) some particles interstitialise through the loose lymphatic capillary endothelium and macrophages begin to accumulate in
response; A3) macrophages and particles form a mature ‘black spot’ with mesenchymal cell activation and proliferation depending on the
toxicity and dose of the particle. B) In B1 a single long fibre is intercepted as it attempts to negotiate the stomatal opening and is retained; 2)
other fibres are caught up and there is an accumulation of retained long fibres; 3) macrophages attempt to phagocytose the fibres and undergo
frustrated phagocytosis releasing a range of pro-inflammatory, genotoxic and mitogenic mediators close to the pleural mesothelial cells. PM =
pleural mesothelium; St = stoma; LC = lymph capillary.
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retained in the parietal pleura?’.
Fibres found in digested human lung and visceral
pleura at autopsy following death from mesothelioma
are often short [49] but, as described below, these are
not the site to seek the effective fibre ‘dose’ for mesothe-
lioma, since the parietal pleura is the site of mesothe-
lioma initiation. In fact the site where the effective dose
for long fibres is initially applied is the parietal mesothe-
lium, which has seldom been sampled for fibre burden
or dimensions. However, in several studies, fibres recov-
ered from the parietal pleura have also been found to be
short [50,51]. This may be explained by the fact that, as
described above, the location of the longer fibres is
likely to be very focal, at the stomata. When this area
was specifically sampled in 14 patients diagnosed with
asbestos-associated diseases, including mesothelioma,
much longer fibres were found concentrated there [5].
Correct sampling is key to determining the important
measure of dose and since this is likely to be found only
in ‘hot-spots’ at stomata but these are heterogeneously
distributed across the parietal pleura, are very small and
so difficult to sample.
Fibre biopersistence and the hypothetical model
In the case of non-biopersistent fibres, the degree of
their biopersistence, specified by the retention half-time,
will dictate the likelihood that they will reach the pleura
and the impact that they will have there. For fibres of
very low biopersistence such as the chrysotile fibres
with half-lives of around 1 day [52] it seems likely such
chrysotile fibres undergo dissolution and breakage in the
lung parenchyma in the hours following deposition,
such that no long fibres are likely to reach the pleura;
only short fibres, if any fibre-like structures remain at
all, are likely to transit to the pleural space. In the case
of fibres that are moderately biopersistent, the long
fibres may retain their structure en route to the pleural
space, all the while undergoing dissolution/breakage. If
long fibres are sufficiently biopersistent to retain their
fibrous structure long enough to enter the pleural space
they may be retained at the parietal stomata, initiating
frustrated phagocytosis and granuloma formation.
Depending on the extent of their biopersistence, how-
ever, fibres could still dissolve and break within the
macrophages as a result of the high pH within the pha-
golysosomes, allowing the granuloma to resolve. The
exact tempo of translocation of particles and fibres to
the pleural space is unknown, but in less than 1 day fol-
lowing inhalation of short, essentially particulate, CNT
in mice, the CNT were evident in the sub-pleural extra-
cellular matrix [53]. This suggests that compact particles
or very short HARN may reach the pleural space rapidly
following deposition; however such short HARN and
compact particles are not likely to be retained at the
stomata. No inhalation study with long CNT has yet
been carried out but fibres long enough to be retained
at the parietal stomata may move more slowly through
the parenchyma, to the pleura, because of their greater
dimensions causing ‘drag’ to their movement through
fluid. Research is needed to elucidate the relationship
between fibre length and biopersistence in leading to
pleural transport, mesothelial injury, inflammation and
mesothelioma.
Carbon nanotubes in the pleura
We approached the issue of the potential mesothelial
toxicity and pleural toxicity of carbon nanotubes by first
attempting to determine whether, similar to asbestos,
carbon nanotubes showed length-dependent toxicity to
the mesothelium. Based on the above argument we also
hypothesise that the long CNT would be retained at the
parietal pleural around the stomata. In early studies we
used the peritoneal mesothelium lining the peritoneal
cavity as the target mesothelium. These studies demon-
s t r a t e dt h a tt h e r ew a si n d e e dl e n g t h - d e p e n d e n ti n f l a m -
mogenicity and fibrogenicity of carbon nanotubes in the
peritoneal cavity, mimicking asbestos [2]. As predicted
from the fibre pathogenicity paradigm, the key length
appeared to be between 15-20 μm, the length beyond
which macrophages cannot stretch and enclose fibres,
thus eliciting frustrated phagocytosis. In the follow up
to the studies we utilised the pleural mesothelium and
developed a model of injection of nanotubes and asbes-
tos into the pleural space of mice. This can be affected
quickly in non-anaesthetised mice using a very fine nee-
dle with a collar at the level of the bevel in the needle
to restrict penetration through the chest wall allowing
injection only into the pleural space. Following injection,
the injectate distributes through the pleural space as was
evident by inspection of lungs immediately following
injection. In these studies we injected the same panel of
fibres used in the peritoneal cavity in the Poland studies,
i.e. long and short amosite asbestos samples, two long
nanotubes samples and two short/tangled nanotubes
samples and nanoparticulate carbon black as a graphene
control. Following injection the pleural cavity was
lavaged to determine the inflammatory response. We
found clear evidence of length-related inflammation in
the pleural space with both the long amosite and the
two long nanotubes samples causing inflammation while
all the other short samples failed to elicit significant
inflammation (Figure 10).
In a time course, the long nanotubes caused a sus-
tained high level of inflammation at 7 days, which was
the same as was present at 1 day. This is in contrast to
the events in the peritoneal space where there is a
decline in inflammatory response over 7 days to levels
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our hypothesis that long fibres were retained at the
parietal pleural and that short fibres were not, we used
paraffin wax histology to examine the parietal pleural
surfaces. In keeping with the hypothesis, long fibres
which were visible on day 1 following injection were
still visible in granulomas at the surface of the parietal
pleura on day 7 (Figure 11). No short fibres were visi-
ble in sections of parietal pleura at 1 or 7 days, how-
ever the activated, thickened mesothelium seen at day
1 had returned to normal by day 7 suggesting that the
short fibres had been cleared (Murphy, F., Poland, C.
A., Ali-Boucetta, H., Al-Jamal K.T., Duffin, R., Nunes,
A . ,H e r r e r o ,M - A . ,M a t h e r ,S .J . ,B i a n c o ,A . ,P r a t o ,M . ,
Kostarelos, Donaldson, K. Long but not short nano-
tubes are retained in the pleural space initiating sus-
tained mesothelial inflammation. Submitted for
publication).
We therefore hypothesise that the retention of long
fires at the stomatal openings on the parietal pleura,
coupled with frustrated phagocytosis of pleural leuko-
cytes that attempt to ingest them, produce a chronic
pleural mesothelial inflammatory response. Chronic
inflammation is known to be a driver for proliferation,
genotoxicity, growth factor synthesis and release that are
likely to culminate in pathology such as fibrosis, pleural
effusion and mesothelioma (Figure 12).
Implications for testing of high aspect ratio
nanoparticles (HARN)
The foregoing discussion has highlighted the importance
of the parietal pleura as the target for the long fibre
hazard following pulmonary deposition and the site of
initiation of mesothelioma. In addition to carbon
nanotubes, there are a whole new generation of high
aspect ratio nanoparticles (HARN), such as nanorods
and nanowires. These are made of a wide range of
materials, including silica, silver, nickel and various
forms of carbon. There is a need to test these materials
and understand their potential for causing mesothe-
lioma. Mesothelioma has a very long latent period and
in rats, following inhalation of asbestos, mesothelioma
commonly does not develop until near the end of life in
a small proportion of animals. The peritoneal cavity has
been used as a more efficient model for mesothelioma
induction but has been criticised because of its non-phy-
siological nature and irrelevance for risk assessment.
However, the peritoneal cavity does show size-restricted
clearance and subsequent sensitivity to retained long
fibres. An appreciation of the role of the parietal pleura
as the site where fibres are retained leading to pleural
pathology of various sorts which accompany exposure to
fibres, means that a rational testing strategy could
attempt to identify early changes in this tissue following
fibre exposure. New techniques that allow investigators
to home in on specific areas, eg laser capture, would
enable the areas of the parietal pleura where the stoma-
tal openings occur to be identified and studied in detail
for the presence of fibres and their molecular conse-
quences. Thus there is the prospect of studying oxida-
tive stress, inflammation and genotoxicity at an early
stage in the very target tissue where mesothelioma is
likely to arise. This should revolutionise the ability to
screen for pathogenic fibres amongst emerging HARN
and allow us to look anew at the effects of asbestos and
more conventional fibres that affect the pleural
mesothelium and we look forward to future studies that
utilise this knowledge.
Figure 10 Cytospin preparations of pleural lavage cells from mice treated with short/tangled CNT (left) and long CNT (right). Arrows
indicate granulocytes. Note PMN and eosinophils (arrows) indicative of inflammation in pleural leukocytes from rats exposed to the long NT only.
Donaldson et al. Particle and Fibre Toxicology 2010, 7:5
http://www.particleandfibretoxicology.com/content/7/1/5
Page 13 of 17Figure 11 Histological sections through the chest wall of mice treated with long straight nanotubes (A, B) or short, tangled
nanotubes (C, D) for 1 or 7 days. Note the progressive thickening of the mesothelium in A and B in response to long straight nanotubes; this
contrasts with the acute thickening of the pleural layer with short/tangled CNT which shows resolution to normal mesothelium by 7 days (D).
Scale bars represent 20 μm.
Figure 12 Hypothesised sequence of events leading to pleural responses as a consequence of long fibre retention at the parietal
pleural stomatal openings.
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The emphasis on the parietal pleura as the site of
retention and focus for the long fibre dose has impor-
tant implications for our understanding of the origins
of mesothelioma, a subject of considerable scientific
and, arguably, even greater medico-legal significance.
Mesothelioma continues to be a global problem due to
o n g o i n ge x p o s u r et of i b r e sa n da sal e g a c yf r o mp a s t
exposure to asbestos, even in countries where asbestos
is currently banned or has been regulated out of use
for decades [54]. Lung tissue burdens of asbestos fibres
have long been used as an index of exposure, but the
above discussion highlighting the parietal pleura, not
t h el u n gt i s s u e ,a st h es i t eo fo r i g i no fm e s o t h e l i o m a
calls into question the relevance of parenchymal lung
fibre burdens as a correlate of mesothelioma. The lung
diseases caused by asbestos i.e. lung cancer and asbes-
tosis - may well be related to the lung parenchyma
tissue burdens, since one would reasonably look in the
target tissue for the effective dose. However the same
logic would dictate that the effective dose for mesothe-
lioma, which arises in the parietal pleura, should be
sought in that tissue. In fact the parietal pleura fibre
burden has been studied, but only very occasionally;
for example Dodson and Atkinson [55] cite Sebastien
[56] as stating that, for asbestos fibre burden “lung
parenchymal retention is not a good indicator of
pleural retention: indeed, there was no relationship
between parenchymal and pleural concentrations”.
This would be predicted from the arguments presented
in this paper. Therefore, whilst the lung parenchyma is
a site of fibre accumulation that is likely related to
exposure, the lung parenchyma is not expected to
focus the effective dose for mesothelioma in the way
that the parietal pleura does [5] through its action as a
kind of ‘sieve’ that selectively retains long fibres.
Even supposing the parietal pleura were to be chosen
as the tissue of choice for assessing effective dose of
long fibre for the mesothelioma hazard, a considerable
problem is posed in sampling it for fibre-burden analysis
because of their small size and the heterogeneous distri-
bution of the stomata over the parietal pleura. Yet these
are exactly the sites that should be sampled in order to
find the dose responsible for the mesothelioma response
or to sample the site of developing mesothelioma in
order to determine its molecular ontogeny. These ‘hot-
spots’ of dose could not be easily selected at autopsy by
a pathologist unless they knew specifically where to look
and even then the diluting effect of non-stomatal tissue
in the immediate vicinity could easily confound any
attempt to determine the specific long fibre dose at the
stomata.
Conclusion
We have reviewed the evidence for the hypothesis for
the behaviour of long fibres in the parietal pleura, focus-
ing on nanotubes as a new potential pleural hazard,
although the discussion is relevant to all fibres including
asbestos. We argue from existing evidence that a frac-
tion of all deposited particles reach the pleura and from
evidence on the mechanism of particle clearance from
the pleura, to argue that the parietal pleura is the site of
retention of long fibres (Figure 10). We suggest that
their retention there, a consequence of length-restricted
clearance through the normal stomatal clearance system,
initiates inflammation and pleural pathology including
m e s o t h e l i o m a .W ec i t ed a t af r o mt h o r a c o s c o p yt os u p -
port the contention that, as would be anticipated from
t h ef o r e g o i n g ,t h ep a r i e t a lp l e u r ai st h es i t eo fo r i g i no f
pleural mesothelioma. This general hypothesis on the
key role of fibre length-restricted clearance from the
pleural space as a mechanism for delivering a high,
focussed, effective dose of long fibres to the mesothelial
cells around the parietal pleural stomata, has important
implications. These lie in future research into the
mesothelioma hazard from HARN but also for our cur-
rent view of the origins of asbestos-initiated pleural
mesothelioma and the use of lung parenchymal fibre
burden as a correlate of this tumour, which arises in the
parietal pleura, not the lung parenchyma or visceral
pleura.
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